UAE News Online
Main » 2017 » February » 10
HIGHLAND HEIGHTS, Ky.-- (BUSINESS WIRE /ME NewsWire)-- General Cable Corporation (NYSE: BGC) reported today results for the fourth quarter ended December 31, 2016. For the quarter, reported diluted loss per share was $2.10 and reported operating loss was $97 million. The Company generated adjusted earnings per share for the quarter of $0.05 and adjusted operating income of $27 million. See page 3 of this press release for the reconciliation of reported to adjusted results and related disclosures. Michael T. McDonnell, President and Chief Executive Officer, said, “In 2016 we achieved significant progress in the execution of our strategic roadmap designed to transform the Company into a more focused, efficient and innovative organization, including the strengthening of the General Cable global management team. We are especially pleased with what we have accomplished in North America, which has been a primary focus of the roadmap during the first year of our three year plan. In 2017, we ... Read more »
Views: 289 | Added by: uaeonlinenews | Date: 02.10.2017 | Comments (0)

INGELHEIM, Germany-Thursday, February 9th 2017 [ ME NewsWire ] Efficacy and safety of afatinib plus pembrolizumab to be assessed in Phase II trial in patients with locally advanced or metastatic squamous cell carcinoma (SqCC) of the lung Afatinib is approved in patients with advanced SqCC of the lung whose disease has progressed after treatment with platinum-based chemotherapy and in patients with specific types of EGFR mutation-positive non-small cell lung cancer (NSCLC) Boehringer Ingelheim continues to explore afatinib beyond the large LUX-Lung programme and its current indications (BUSINESS WIRE)-- Boehringer Ingelheim today announced the initiation of a Phase II trial of afatinib* (Giotrif®) in combination with pembrolizumab (Keytruda®) for patients with locally advanced or metastatic squamous cell carcinoma (SqCC) of the lung. Benjamin Levy, MD, Clinical Director, Sidney Kimmel Cancer Center, Johns Hopkins Medicine at Sibley Memorial Hospital Washington DC, USA said, “Given ... Read more »
Views: 275 | Added by: uaeonlinenews | Date: 02.10.2017

—Revenue and profit rise excluding foreign exchange effects— IWATA, Japan-Thursday, February 9th 2017 [ ME NewsWire ] (BUSINESS WIRE)-- Yamaha Motor Co., Ltd. (TOKYO:7272) (ISIN:JP3942800008) announced today that in its fiscal 2016 year, which finished on December 31, net income increased 5.2 percent to 63.2 billion yen thanks to business expansion in emerging markets and improved profitability in various business sectors. Net sales decreased 7.9 percent to 1,502.8 billion yen and ordinary income fell 18.5 percent to 102.1 billion yen. In motorcycles, unit sales and operating income were strong in emerging markets such as India, Vietnam and the Philippines, thanks to increased sales of higher-priced products and cost reductions. Global net sales decreased due to foreign exchange effects. In developed markets, continued progress was achieved with initiatives to reduce inventories, improve financial positions and carry out structural reforms. In the marine sector, outboard motor un ... Read more »
Views: 303 | Added by: uaeonlinenews | Date: 02.10.2017 | Comments (0)

YOKKAICHI, Japan-Thursday, February 9th 2017 [ ME NewsWire ] (BUSINESS WIRE)-- Toshiba Corporation (TOKYO:6502) today announced that it has started construction of a new state-of-the-art semiconductor fabrication facility, Fab 6, and a new R&D center, the Memory R&D Center, at Yokkaichi Operations in Mie prefecture, Japan, the company’s main memory production base. Fab 6 will be dedicated to production of BiCS FLASH™, Toshiba’s innovative 3D Flash memory1. Like Fab 5, construction will take place in two phases, allowing the pace of investment to be optimized against market trends, with completion of Phase 1 scheduled for summer 2018. Toshiba will determine installed capacity and output targets and schedules by closely monitoring the market. Toshiba will also construct a Memory R&D Center adjacent to the new fab, with completion targeting December 2017. The facility will advance development of BiCS FLASH™ and new memories. Toshiba is determined to enhance its competitiveness in the ... Read more »
Views: 281 | Added by: uaeonlinenews | Date: 02.10.2017 | Comments (0)

TOKYO-Thursday, February 9th 2017 [ ME NewsWire ] (BUSINESS WIRE)-- Toshiba Tec Corporation (TOKYO: 6588) today announced that the document solutions of Nuance, the strategic partner of Toshiba Tec, has been added to its portfolio: AutoStore and Equitrac. Through the strategic partnership with Nuance which is a leading provider of speech and imaging solutions, Toshiba Tec extends its range of document solutions to improve workflows, manage output and help businesses operate more efficiently and securely. Nuance’s software solutions optimize and automate document workflows and seamlessly integrate into an existing IT infrastructure. With the Toshiba e-STUDIO MFPs being an essential part of these improved workflow automations, companies benefit from reduced cost and the increased value that MFP has to their business. Toshiba offers its customers the following Nuance products: AutoStore The award-winning capture and creation solution provides a unique experience designed with a respo ... Read more »
Views: 266 | Added by: uaeonlinenews | Date: 02.10.2017

Inaugural Americas Event Set to Attract 30,000 Attendees and 1,000 Exhibitors ATLANTA -Thursday, February 9th 2017 [ ME NewsWire ] (BUSINESS WIRE)-- The GSMA today announced the first details of the 2017 GSMA Mobile World Congress Americas, in partnership with CTIA, including confirmed exhibitors, partners, programmes and activities taking place at the new mobile industry event. Under the theme “The Tech Element”, Mobile World Congress Americas will be held September 12 – 14, 2017 at the Moscone Center in San Francisco. It is expected that 30,000 professionals from across the mobile industry and adjacent industry sectors will attend Mobile World Congress Americas 2017. “We are very excited to be launching Mobile World Congress Americas, our first large-scale event addressing North, Central and South America, with our partner CTIA,” said Michael O’Hara, Chief Marketing Officer, GSMA. “Mobile World Congress Americas will highlight innovation in areas such as 5G and next-generation ne ... Read more »
Views: 327 | Added by: uaeonlinenews | Date: 02.10.2017 | Comments (0)

June 26-27, 2017, Paris, France VILLEJUIF, France-Thursday, February 9th 2017 [ ME NewsWire ] (BUSINESS WIRE)-- WIN 2017 Symposium will be held in Paris, France from June 26-27, 2017. The CME accredited WIN2017 is an exceptional scientific event dedicated to “Expediting Global Innovation in Precision Cancer Medicine’’ addressed to all cancer care professionals. “The 2016 WIN symposium brought together some of most distinguished lecturers from around the world covering a broad array of topics that are likely to have a direct impact on the treatment of most of our patients with cancer.” said Bruce E. Johnson, President of ASCO® 2017-2018, who delivered a keynote lecture in the last edition. ASCO® has endorsed the WIN Symposium for the past eight consecutive years. John Mendelsohn, Chair of WIN Consortium and Past President of The University of Texas MD Anderson Cancer Center will present in his Welcome Address an overview of WIN disruptive programs aiming to significantly improve ... Read more »
Views: 280 | Added by: uaeonlinenews | Date: 02.10.2017 | Comments (0)

VILLEJUIF, France-Vendredi 10 Février 2017 [ ME NewsWire ] (BUSINESS WIRE)--Le Symposium WIN 2017 se tiendra à Paris les 26 et 27 juin 2017. Ouvrant droit à des crédits de formation médicale continue (CME), le symposium WIN 2017 consacré au thème « Accélérer l’innovation mondiale pour la médecine de précision du cancer » est un évènement d’exception destiné à tous les professionnels de l’oncologie. « L’édition 2016 du symposium WIN a réuni certains des chercheurs les plus reconnus au plan mondial. Ils se sont exprimés sur un large éventail de thèmes susceptibles d’avoir un impact direct sur le traitement de la plupart de nos patients atteints de cancer », a déclaré Dr Bruce E. Johnson, président de l’American Society of Clinical Oncology® (ASCO®) 2017-2018, qui est intervenu lors de la dernière édition du symposium WIN. L'ASCO® a accrédité le Symposium WIN depuis les huit dernières années. Dr John Mendelsohn, président du Consortium WIN et ancien président du MD Anderson Cancer Cen ... Read more »
Views: 287 | Added by: uaeonlinenews | Date: 02.10.2017 | Comments (0)